Rasagiline mesylate | 2237

Rasagiline is a selective and irreversible inhibitor of monoamine oxidase (MAO) that has been used as a monotherapy in early Parkinson’s disease or as an adjunct therapy in more advanced cases.

Rasagiline is a selective and irreversible inhibitor of monoamine oxidase (MAO)

2237 | Rasagiline mesylate DataSheet

Alternate Name/Synonyms: (1R)-2,3-Dihydro-N-2-propynyl-1H-inden-1-amine methanesulfonate

Appearance: White solid

Formulation: N/A

CAS Number: 161735-79-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₂H₁₃N ∙ CH₃SO₃H

Molecular Weight: 267.34

Cell-Permeable?: Yes

Purity: ≥99%

Solubilities: DMSO (>20 mg/ml) or H₂O (>20 mg/ml)

Handling: Protect from light and moisture

Country of Origin: USA

Tag Line: A selective and reversible monoamine oxidase (MAO) inhibitor

MDL Number: MFCD08460604

PubChem CID: 3052775

SMILES: CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12

InChi: InChI=1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m1./s1

InChi Key: JDBJJCWRXSVHOQ-UTONKHPSSA-N